Lactobacillus crispatus LV5 and Improved CST Status to CST I

• Oral administration of Lactobacillus crispatusM247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.

  • 2021-11
  • Clinical Trial · n = 35
  • Minerva Obstetrics and Gynecology 73(5)
  • • F. Di Pierro
    • A. Criscuolo
    • Anna Dei Giudici
    • R. Senatori
    • F. Sesti
    • M. Ciotti
    • E. Piccione

  • PubMed: 33876901
  • DOI: 10.23736/S2724-606X.21.04752-7

  3 Insights on

  • Improved CST Status to CST I

  • High evidence

  After 90 days of oral treatment with a probiotic (L. crispatus M247)... a significant change in CST status with 94% of women now classified as CST I.

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes